3DHISTECH

3DHISTECH

Budapest, Hungary· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $7.6M

Overview

3DHISTECH is a pioneering, privately-held digital pathology company with over 30 years of experience, headquartered in Budapest, Hungary. It has established itself as a full-spectrum vendor offering hardware, software, and services for the complete digitization of pathology workflows, serving both clinical diagnostics and life science research markets. The company has a significant installed base of over 3,800 units and is expanding its portfolio with innovative technologies like 3D micro-CT imaging. Recent regulatory certifications (IVDR, MDSAP) underscore its focus on quality and global market expansion, particularly in diagnostics.

Oncology

Technology Platform

Integrated digital pathology platform comprising the Pannoramic family of whole slide scanners (brightfield, fluorescence, confocal, polarization), the Pannoramic-X micro-CT scanner for 3D tissue imaging, and a suite of software for image analysis, management, and 3D visualization (DVREAL).

Funding History

2
Total raised:$7.6M
Series A$5.5M
Grant$2.1M

Opportunities

The accelerating global transition to digital pathology in clinical diagnostics, driven by regulatory approvals for primary diagnosis, represents a massive growth opportunity.
The company's recent IVDR and MDSAP certifications are key enablers for this expansion.
Furthermore, its innovative Pannoramic-X micro-CT scanner creates a new market in 3D spatial biology for research, addressing unmet needs in complex tissue analysis for oncology and neuroscience.

Risk Factors

Intense competition from larger, global medical technology corporations with greater resources and established commercial networks poses a significant market challenge.
The company also faces regulatory execution risk, as the costly and complex process of obtaining and maintaining certifications (like IVDR for AI software modules) is critical for diagnostic market access but subject to evolving standards and potential delays.

Competitive Landscape

3DHISTECH competes in the digital pathology market against major players like Roche (Ventana), Philips, Leica Biosystems (Danaher), and Hamamatsu. Its competitive differentiation lies in its claimed scanner speed, a comprehensive range of imaging modalities within single devices, its integrated vendor-locked ecosystem, and its novel micro-CT technology for 3D imaging, which is less common among mainstream pathology vendors.